Navigation Links
Polaris Group Appoints Robert E. Hoffman as Chief Financial Officer
Date:3/15/2011

SAN DIEGO, March 15, 2011 /PRNewswire/ -- Polaris Group today announced the appointment of Robert E. Hoffman as chief financial officer.

Hoffman has joined Polaris from Arena Pharmaceuticals Inc., where he held senior financial positions for more than 13 years. Most recently, Hoffman was vice president of finance and chief financial officer. In his leadership roles, Hoffman contributed to the success of Arena's initial public offering in 2000 and other equity, debt and collaborative  transactions that totaled nearly $1.5 billion as Arena built a pipeline of drug candidates and completed a Phase 3 pivotal program for its lead candidate.

"Robert brings extensive financial management experience from a public, late-stage development company to Polaris Group at a pivotal time," said Bor-Wen Wu, Ph.D., president and chief executive officer of Polaris Group. "We are moving our lead project, ADI-PEG 20, into a Phase 3 trial in hepatocellular carcinoma as well as advancing multiple Phase 2 trials in other cancer types. In line with our clinical progress, we are expanding our management team as Polaris transforms into a late-stage clinical development company."

Hoffman currently serves as a member of the Financial Accounting Standards Board's small business advisory committee and the steering committee of the Association of Bioscience Financial Officers. In addition, he is a member and former president of the San Diego chapter of Financial Executives International and a director of the charitable organization Day For Change. Hoffman earned a bachelor's degree in business administration from St. Bonaventure University.

"I am excited about the opportunity to participate in Polaris' transformation into a late-stage company," said Hoffman. "Lead project ADI-PEG 20 represents a significant opportunity in the treatment of many cancer types. I look forward to working with the Polaris team to advance this promising drug candidate through its final
'/>"/>

SOURCE Polaris Group
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Home Medical Equipment Group Supports Bipartisan Bill to Repeal the Controversial Medicare Competitive Bidding Program for Homecare
2. Southern Home Medical Equipment Engages Northern Virginia Based Waterford Holdings Group to Evaluate and Consider Acquisition Candidates in the Mid-Atlantic Area
3. LaVoie Group Wins Gold Mercury Award For Medical Device Company, Alphatec Spine
4. LaVoie Group Wins Two Mercury Excellence Awards
5. Sinovac Reports Positive Preliminary Phase I Clinical Trial Results for EV71 Vaccine in Adult Group
6. Software Development Firms New Intellectual Property Group, Blue Horseshoe IP Creates Solutions to Help Customers Optimize Supply Chain
7. Simcere Pharmaceutical Group Reports Unaudited Fourth Quarter and Fiscal Year 2010 Results
8. Rottenstein Law Group Applauds New Efforts of U.S. FDA to Look More Carefully at Metal-on-Metal Implants After DePuy Recall
9. PCMA: Anti-Fraud Group Spotlights Policies that Promote Health Care Fraud and Abuse
10. New Image Global, Inc. Partners With Limbs For U, Charitable Service Group to Provide Prosthetic Limbs in the Dominican Republic
11. Deb Group Introduces First Real-time Hand Hygiene Group Monitoring System Based on World Health Organization Guidelines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... , Aug. 4, 2015 Among 1,000 ... medications, yet only half of consumers surveyed are aware ... have ever used use them, according to findings from ... a community service partnership focused on improving the health ... The online survey polled 1,000 men and women, ages ...
(Date:8/3/2015)... --  The Intellectual Property and Science business of ... intelligent information for businesses and professionals announced the ... Factbook , the biopharmaceutical industry,s leading resource of ... R&D, the analysis identifies a surge in global ... sales to reach $1.3 trillion by 2018. It ...
(Date:8/3/2015)... , Aug. 3, 2015 Discovery Laboratories, ... company focused on developing aerosolized KL4 surfactant therapies ... and webcast at 8:30 a.m. Eastern Time on Tuesday ... discuss the 2015 second quarter financial results along ... issue a press release announcing the second quarter ...
Breaking Medicine Technology:New Study Finds Consumers are Leaving Money at the Pharmacy 2New Study Finds Consumers are Leaving Money at the Pharmacy 3Pharma Sales to Grow Beyond $1 Trillion 2Discovery Labs to Hold Conference Call on Tuesday August 11, 2015 to Discuss Second Quarter 2015 Financial Results and Other Business Updates 2
... 11 InteKrin Therapeutics, Inc., a clinical stage biopharmaceutical ... it has completed enrollment of a 360 patient Phase ... of PPAR gamma (SPPARM) for the treatment of Type ... high dose active comparator (45mg Actos(R)) and placebo controlled ...
... BioSpecifics Technologies Corp. (Nasdaq: BSTC ), ... today announced that BioSpecifics, President, Tom Wegman, will present ... 29th Annual Health Care Conference on Tuesday, March 17, ... Place in Boston, MA. A live webcast of the ...
Cached Medicine Technology:InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study 2
(Date:8/4/2015)... ... August 04, 2015 , ... Updated enrollment data on the ... team, can now be accessed at http://www.AISHealth.com . The data is free to ... Plans: 2015, the tables and charts on the website’s “Data” section include:, ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... Rock Your ... Pop & Rock Beauty Bash Tour. In addition, they have signed Lexi Noel, dubbed ... will appear in forthcoming print and overall branding opportunities for the company. , ...
(Date:8/4/2015)... New York, NY (PRWEB) , ... August 04, 2015 , ... ... is all but universal, though the desire for invasive surgery to achieve this ideal ... can offer the results people crave without the high cost or lengthy recovery time, ...
(Date:8/4/2015)... , ... August 04, 2015 , ... ... awarded independent educational grants in support of an interaction simulation session entitled "NOACS: ... activity is jointly provided by Medical Learning Institute Inc. and EDUmotion US LLC. ...
(Date:8/4/2015)... ... August 04, 2015 , ... Following last month’s successful rollout of its ... Cath Lab Accreditation in an Academic Setting, and The Importance of PVI Accreditation. , ... taped during the 2015 Society for Cardiovascular Angiography and Interventions (SCAI) Scientific Sessions in ...
Breaking Medicine News(10 mins):Health News:Atlantic Information Services Website Offers Up-to-Date U.S. Health Plan Enrollment Data 2Health News:Rock Your Hair Signs On As Title Sponsor For The HYPE! Projects Pop & Rock Beauty Bash Tour 2Health News:Considering fillers, tighteners or laser resurfacing? 2Health News:Considering fillers, tighteners or laser resurfacing? 3Health News:Considering fillers, tighteners or laser resurfacing? 4Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 2Health News:Innovative Medical Interactive Simulation Session to be presented at upcoming Continuing Education Company Education (CME) Conferences. 3Health News:Accreditation for Cardiovascular Excellence (ACE) Clients Explain Benefits of ACE Accreditation 2Health News:Accreditation for Cardiovascular Excellence (ACE) Clients Explain Benefits of ACE Accreditation 3
... SPRINGS, Fla., Jan. 31 Tigris Pharmaceuticals,Inc., a privately ... of Mr. Pedro Granadillo to its Board of Directors., ... Eli Lilly and,Company ("Lilly") until 2004 when he retired ... Policy Committee, which was comprised of its top,seven executives. ...
... ... Rebranding, COLUMBIA, S.C., Jan. ... involves the sole sponsorship for the,"One-on- One" match-up analysis to run ... remainder of the regular NCAA season., (Logo: http://www.newscom.com/cgi-bin/prnh/20080109/CLW033LOGO ...
... Guidance -, BRAINTREE, Mass., Jan. 31 Haemonetics,Corporation ... 2008 GAAP net,revenues of $135 million, up 18.6%; net ... share of $0.54, down 12.1%., Third quarter fiscal ... and 2008 and certain tax benefits in 2007, was ...
... took the B vitamin for one year before conception, study ... to help prevent birth defects, folic acid may also help ... study that included almost 40,000 women, a team of U.S. ... supplements for a year or longer before conception had a ...
... Strong International Performance and InLight ... Equipment Sales, GLENWOOD, ... and environmental radiation,monitoring, today reported record performance in its first fiscal quarter,ended ... Revenue reached a record $21.8 million on higher international revenues ...
... /PRNewswire-FirstCall/ - DRAXIS Health Inc. (TSX:,DAX) (Nasdaq: DRAX ... Quarter and Year End 2007 on Thursday February 7, ... audio webcast at 10:00 a.m.,(ET) to discuss the results ... the conference call and webcast are as follows:, ...
Cached Medicine News:Health News:Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors 2Health News:Tigris Pharmaceuticals Appoints Pedro Granadillo to Board of Directors 3Health News:Colonial Life Goes 'One On One' With ESPN 2Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 2Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 3Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 4Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 5Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 6Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 7Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 8Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 9Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 10Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 11Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 12Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 13Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 14Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 15Health News:Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales 16Health News:Folic Acid May Help Prevent Premature Birth 2Health News:Folic Acid May Help Prevent Premature Birth 3Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 2Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 3Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 4Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 5Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 6Health News:Landauer, Inc. Reports Strong Fiscal 2008 First Quarter Results 7Health News:DRAXIS to Report Fourth Quarter and Year End 2007 Results on February 7th 2Health News:DRAXIS to Report Fourth Quarter and Year End 2007 Results on February 7th 3Health News:DRAXIS to Report Fourth Quarter and Year End 2007 Results on February 7th 4
... T is a quadripolar pacing ... pacing and monitoring during and ... 227 T features tines for ... allows safe and easy implantation ...
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
For temporary cardiac pacing after open heart surgery. The zig-zag portion of the heartwire is embedded into the desired area of the myocardium (epicardially)....
Medicine Products: